Sodium Iodide → 8-(6-Chloro-2-iodopyrimidin-4-yl)-3-oxa-8-azabicyclo[3.2.1]octane
Reaction equation
Cl[C:2]1[N:7]=[C:6]([N:8]2[CH:13]3[CH2:14][CH2:15][CH:9]2[CH2:10][O:11][CH2:12]3)[CH:5]=[C:4]([Cl:16])[N:3]=1.[I-:17].[Na+].I>C(Cl)(Cl)Cl.O>[Cl:16][C:4]1[N:3]=[C:2]([I:17])[N:7]=[C:6]([N:8]2[CH:13]3[CH2:14][CH2:15][CH:9]2[CH2:10][O:11][CH2:12]3)[CH:5]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 0 °C
Procedure
In a 250 mL round-bottomed flask was placed 8-(2,6-dichloropyrimidin-4-yl)-3-oxa-8-azabicyclo[3.2.1]octane (34, 980 mg, 3.77 mmol) in chloroform (4 ml) to give a very light yellow solution. Sodium iodide (941 mg, 6.28 mmol) was added to give a suspension. The mixture was cooled to 0° C. and an aqueous solution (57% w/w) of hydrogen iodide (4.97 ml, 37.7 mmol) was added, resulting in a yellow precipitate. The mixture was slowly warmed to room temperature and stirred at room temperature for 4 h. The mixture was diluted with water and quenched with NaOH (5M) to pH˜8. Aqueous sodium thiosulfate was added to decolorize. The mixture was extracted with dichloromethane, dried over MgSO4 and concentrated. The crude product was added to a silica gel column and was eluted with ethyl acetate in hexanes (10-40%). Collected fractions were concentrated to give the title compound (516 mg) as a white solid. LCMS analysis revealed that the product contained ˜20% starting material. The mixture was used without further purification in the next step.
Workup
- customIn a 250 mL round-bottomed flask was placed
- customto give a suspension
- customresulting in a yellow precipitate
- temperatureThe mixture was slowly warmed to room temperature
- customquenched with NaOH (5M) to pH˜8
- additionAqueous sodium thiosulfate was added
- extractionThe mixture was extracted with dichloromethane
- dry with materialdried over MgSO4
- concentrationconcentrated
- additionThe crude product was added to a silica gel column
- washwas eluted with ethyl acetate in hexanes (10-40%)
- concentrationCollected fractions were concentrated
Sources & evidence
- ORD record
- ord-4154d87023ea401f98c68234a7cdf863
- Source dataset
- uspto-grants-2014_09
- Patent number
- US08835429B2
Reaction notes
Loading…